Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0VA9Z
|
|||
| Drug Name |
ND0612
|
|||
| Synonyms |
Carbidopa and levodopa; Duodopa; Nakom; Nacom; Sinemet CR; Dopabain; Isicom; Co-careldopa; Levodopa-carbidopa (10:1); Carbidopa-levodopa (1:10); CARBIDOPA AND LEVODOPA; CHF 1512; Rytary; Duopa; Sinemet CR4; L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid (10:1); L-Tyrosine, 3-hydroxy-, mixt. with (S)-alpha-hydrazino-3,4-dihydroxy-alpha-methylbenzenepropanoic acid; Levodopa / carbidopa; Carbidopa / Levodopa; Carbidopa-levodopa ER; Carbidopa-L-dopa mixt.; Carbidopa-levodopa mixt.; Levodopa/Ca
Click to Show/Hide
|
|||
| Indication | Parkinson disease [ICD-11: 8A00.0; ICD-9: 332] | Phase 2 | [1] | |
| Company |
Mitsubishi Tanabe Pharma America Jersey City, NJ
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H25N3O8
|
|||
| Canonical SMILES |
CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.C1=CC(=C(C=C1CC(C(=O)O)N)O)O
|
|||
| InChI |
1S/C10H14N2O4.C9H11NO4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6;10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h2-4,12-14H,5,11H2,1H3,(H,15,16);1-2,4,6,11-12H,3,10H2,(H,13,14)/t10-;6-/m00/s1
|
|||
| InChIKey |
IVTMXOXVAHXCHI-YXLMWLKOSA-N
|
|||
| CAS Number |
CAS 57308-51-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.